Skip to main content

Drug Strategies

Washington, District of Columbia·EIN 52-1837390·NTEE W20Z · Public & Societal Benefit·501(c)(3)·Filing year 2023

Drug Strategies's highest-paid officer, the Executive Dir/president, was reported at $118,300 for 2023 (IRS Form 990), including base pay and other compensation. Reported CEO pay ranged from $107,027 to $118,300 between 2022 and 2023.

Total revenue
$1.9M
Total assets
$1.9M
Total expenses
$375k
Reported officers
8

How Drug Strategies’s pay compares

Compared with Public & Societal Benefit organizations of similar size in the District of Columbia.

Below peers

Most of the roles Drug Strategies reports are paid below the middle half of what these Public & Societal Benefit organizations pay for the same roles.

Show how each role compares

From the officer pay Drug Strategies reported on its latest IRS Form 990.

DRUG STRATEGIES PROMOTES MORE EFFECTIVE APPROACHES TO THE NATION'S DRUG PROBLEMS AND SUPPORTS PRIVATE AND PUBLIC EFFORTS TO REDUCE THE DEMAND FOR DRUGS THROUGH PREVENTION, EDUCATION AND TREATMENT.

Executive compensation

Form 990 · Part VII & Schedule J · 1 reported individual · Filing year 2023

Percentile bands compare each position's total pay with the same role at Public & Societal Benefit organizations of similar size in the District of Columbia.

Executive Dir/president
10th to 25th percentile
$118k

Plus 7 unpaid individuals.

Browse compensation in Public & Societal Benefit →

Top pay as a share of expenses

In 2023, the highest total compensation at Drug Strategies equaled 32% of the organization's total expenses. The median for public & societal benefit organizations is 10%.

This organization (2023)
32%
Sector median
10%
Middle half of sector
4% to 22%

Based on 2,608 public & societal benefit organizations, each measured at its most recent filing year with reported expenses and compensation.

Up 11%
from 2022

From $107k in 2022 to $118k in 2023.

$107k
2022
$118k
2023
Pay for the position

Chief Executive Officer pay rose 11% from 2022 to 2023, while revenue rose 2446%.

$107k in 2022 to $118k in 2023.

Pay for the position itself, not any one person. The officeholder may have changed between 2022 and 2023.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Common questions about Drug Strategies

What does the Chief Executive Officer of Drug Strategies earn?

In 2023, the Chief Executive Officer of Drug Strategies received $118,300 in total compensation. This pay is in the bottom quarter for Chief Executive Officer roles among Public & Societal Benefit organizations of similar size in the District of Columbia, above the lowest 10% of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at Drug Strategies compare with similar nonprofits?

Compared with the same role at Public & Societal Benefit organizations of similar size in the District of Columbia, the 2023 pay of the Chief Executive Officer at Drug Strategies falls between the 10th and 25th percentiles. In 2023, the highest total compensation at Drug Strategies equaled 32% of the organization's total expenses. The median for public & societal benefit organizations is 10%.

What are Drug Strategies's revenue and expenses?

In 2023, Drug Strategies reported $1.9M in total revenue and $375k in total expenses on its IRS Form 990.